Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

BACKGROUND: Even though chemotherapy-induced nausea and vomiting (CINV) can be well controlled in the acute phase, the incidence of delayed CINV remains high. In this study, we intend to investigate whether prolonged use of NK-1 receptor antagonist (RA) in addition to 5-HT3 RA and dexamethasone (DEX...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ai, Guan, Shasha, Sun, Yinjuan, Wang, Lingling, Meng, Fanlu, Liu, Xia, Gu, Liyan, Li, Guo, Zhong, Diansheng, Zhang, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314477/
https://www.ncbi.nlm.nih.gov/pubmed/37393241
http://dx.doi.org/10.1186/s12885-023-11070-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314477/
https://www.ncbi.nlm.nih.gov/pubmed/37393241
http://dx.doi.org/10.1186/s12885-023-11070-3

Ejemplares similares